文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

神经艾滋病中的血脑屏障。

The blood-brain barrier in neuroAIDS.

作者信息

Banks Wiliam A, Ercal Nuran, Price Tulin Otamis

机构信息

Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center-St. Louis, St. Louis, MO 63106, USA.

出版信息

Curr HIV Res. 2006 Jul;4(3):259-66. doi: 10.2174/157016206777709447.


DOI:10.2174/157016206777709447
PMID:16842079
Abstract

Nearly every aspect of blood-brain barrier (BBB) function is involved in or affected by HIV-1. The disruption of the BBB tends to be minimal and is not likely the mechanism by which infected immune cells and virus enter the brain. Instead, immune cells, virus and viral proteins likely activate brain endothelial cells and enable their own passage across the BBB by way of highly regulated processes such as diapedesis and adsorptive endocytosis. Viral proteins and cytokines can enter the CNS from the blood and provide a mechanism by which HIV-1 can affect CNS function independent of viral transport. Brain endothelial cells can also secrete neuroimmunoactive substances when stimulated by HIV-1, gp120, and Tat. Efflux systems such as p-glycoprotein transport anti-virals in the brain-to-blood direction, thus hampering effective accumulation of drug by the CNS. Overall, the BBB plays a major role in establishing and maintaining virus within the CNS and neuroAIDS.

摘要

血脑屏障(BBB)功能的几乎每个方面都与HIV-1相关或受其影响。血脑屏障的破坏往往很小,不太可能是受感染的免疫细胞和病毒进入大脑的机制。相反,免疫细胞、病毒和病毒蛋白可能会激活脑内皮细胞,并通过诸如渗出和吸附性胞吞作用等高度调控的过程使其自身穿过血脑屏障。病毒蛋白和细胞因子可从血液进入中枢神经系统,并提供一种机制,使HIV-1能够独立于病毒转运而影响中枢神经系统功能。当受到HIV-1、gp120和Tat刺激时,脑内皮细胞也可分泌神经免疫活性物质。诸如P-糖蛋白等外排系统将抗病毒药物从脑内向血液方向转运,从而阻碍中枢神经系统有效蓄积药物。总体而言,血脑屏障在中枢神经系统内病毒的建立和维持以及神经艾滋病中起主要作用。

相似文献

[1]
The blood-brain barrier in neuroAIDS.

Curr HIV Res. 2006-7

[2]
HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.

Brain Res. 2005-5-31

[3]
Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders.

J Neurovirol. 1999-12

[4]
CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

J Neurosci. 2006-1-25

[5]
Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis.

J Virol. 2001-5

[6]
Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide.

Exp Neurol. 1999-3

[7]
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.

J Leukoc Biol. 2006-3

[8]
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.

Adv Drug Deliv Rev. 2016-8-1

[9]
Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Cell Mol Neurobiol. 2005-2

[10]
Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.

J Neuroimmune Pharmacol. 2006-6

引用本文的文献

[1]
Molecular Role of HIV-1 Human Receptors (CCL5-CCR5 Axis) in neuroAIDS: A Systematic Review.

Microorganisms. 2024-4-12

[2]
The role of the blood-brain barrier during neurological disease and infection.

Biochem Soc Trans. 2023-4-26

[3]
Models of the Blood-Brain Barrier: Tools in Translational Medicine.

Front Med Technol. 2021-2-15

[4]
CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.

Mol Neurodegener. 2021-11-22

[5]
Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Mol Biomed. 2020

[6]
Impact of Tobacco Smoke in HIV Progression: a Major Risk Factor for the Development of NeuroAIDS and Associated of CNS Disorders.

Z Gesundh Wiss. 2020-6

[7]
Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies.

Open Biol. 2020-12

[8]
Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier.

mBio. 2020-10-20

[9]
Antiretroviral drug-S for a possible HIV elimination.

Int J Physiol Pathophysiol Pharmacol. 2019-8-15

[10]
The Association of Immune Markers with Cognitive Performance in South African HIV-Positive Patients.

J Neuroimmune Pharmacol. 2019-8-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索